1. Home
  2. ORIC vs TWO Comparison

ORIC vs TWO Comparison

Compare ORIC & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • TWO
  • Stock Information
  • Founded
  • ORIC 2014
  • TWO 2009
  • Country
  • ORIC United States
  • TWO United States
  • Employees
  • ORIC N/A
  • TWO N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • TWO Real Estate Investment Trusts
  • Sector
  • ORIC Health Care
  • TWO Real Estate
  • Exchange
  • ORIC Nasdaq
  • TWO Nasdaq
  • Market Cap
  • ORIC 1.1B
  • TWO 1.0B
  • IPO Year
  • ORIC 2020
  • TWO 2009
  • Fundamental
  • Price
  • ORIC $13.16
  • TWO $9.72
  • Analyst Decision
  • ORIC Strong Buy
  • TWO Buy
  • Analyst Count
  • ORIC 8
  • TWO 8
  • Target Price
  • ORIC $16.57
  • TWO $12.43
  • AVG Volume (30 Days)
  • ORIC 1.5M
  • TWO 1.6M
  • Earning Date
  • ORIC 11-06-2025
  • TWO 10-27-2025
  • Dividend Yield
  • ORIC N/A
  • TWO 13.99%
  • EPS Growth
  • ORIC N/A
  • TWO N/A
  • EPS
  • ORIC N/A
  • TWO N/A
  • Revenue
  • ORIC N/A
  • TWO $532,207,999.00
  • Revenue This Year
  • ORIC N/A
  • TWO N/A
  • Revenue Next Year
  • ORIC N/A
  • TWO N/A
  • P/E Ratio
  • ORIC N/A
  • TWO N/A
  • Revenue Growth
  • ORIC N/A
  • TWO 498.21
  • 52 Week Low
  • ORIC $3.90
  • TWO $9.30
  • 52 Week High
  • ORIC $14.93
  • TWO $14.28
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 54.79
  • TWO 48.59
  • Support Level
  • ORIC $12.75
  • TWO $9.30
  • Resistance Level
  • ORIC $13.80
  • TWO $9.95
  • Average True Range (ATR)
  • ORIC 0.72
  • TWO 0.22
  • MACD
  • ORIC -0.08
  • TWO -0.00
  • Stochastic Oscillator
  • ORIC 58.97
  • TWO 64.62

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

Share on Social Networks: